A carregar...
Neurosarcoidosis following Immune Checkpoint Inhibition
Recently, immune checkpoint inhibitors have revolutionized cancer care by enhancing anti-tumor immunity. However, by virtue of stimulating the immune system, they can lead to immune-related adverse events (irAEs). Neurologic irAEs are uncommon but are becoming increasingly recognized and can be quit...
Na minha lista:
| Publicado no: | Case Rep Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6120397/ https://ncbi.nlm.nih.gov/pubmed/30186134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000491599 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|